Annexon Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Annexon Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ANNX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001528115
Board of directors
-
Bettina M. Cockroft · DirectorSince 2023
-
Douglas Love · Director · PRESIDENT AND CEOSince 2023
-
Jung Choi · DirectorSince 2023
-
Mark S. Blumenkranz · DirectorSince 2026
-
Muneer A. Satter · DirectorSince 2023
-
Thomas G. Wiggans · DirectorSince 2023
-
William A. Jones Jr. · DirectorSince 2025
-
William D. Waddill · DirectorSince 2023
-
William H. Carson · DirectorSince 2023
Chief executives
Douglas Love
· President & CEO
Dates unknown
Board connections
5 of this board's directors also sit on 7 other boards.
- via William A. Jones Jr.
- via William D. Waddill
- via Bettina M. Cockroft
- via Thomas G. Wiggans
- via Mark S. Blumenkranz
- via Thomas G. Wiggans
- via William D. Waddill
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $12,318,919
- 14 purchases by 3 insiders
- Sold, last 12 months
- $313,428
- 10 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Option exercise | +30,646 | $1.85 | $56,695 |
| May 28, 2026 | Muneer A. Satter Director | Open-market purchase | +613,497 | $5.41 | $3,319,019 |
| May 11, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $5.78 | $46,240 |
| Apr 10, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $6.20 | $49,600 |
| Mar 10, 2026 | William H. Carson Director | Open-market purchase | +8,000 | $5.67 | $45,360 |
| Mar 2, 2026 | Dananberg Jamie Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −5,820 | $5.43 | $31,603 |
| Mar 2, 2026 | Overdorf Michael Officer (EVP & CHIEF BUSINESS OFFICER) | Open-market sale | −4,339 | $5.42 | $23,517 |
| Mar 2, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Open-market sale | −5,566 | $5.42 | $30,168 |
| Mar 2, 2026 | ARTIS DEAN RICHARD Officer (EVP & CHIEF SCIENTIFIC OFFICER) | Open-market sale | −5,894 | $5.43 | $32,004 |
| Mar 2, 2026 | Jennifer Lew Officer (EVP & CHIEF FINANCIAL OFFICER) | Open-market sale | −5,565 | $5.42 | $30,162 |
| Feb 19, 2026 | Dananberg Jamie Officer (CHIEF MEDICAL OFFICER) | Grant or award | +56,250 | — | — |
| Feb 19, 2026 | Overdorf Michael Officer (EVP & CHIEF BUSINESS OFFICER) | Grant or award | +62,500 | — | — |
| Feb 19, 2026 | ARTIS DEAN RICHARD Officer (EVP & CHIEF SCIENTIFIC OFFICER) | Grant or award | +62,500 | — | — |
| Feb 19, 2026 | Yednock Ted Officer (EVP & CHIEF INNOVATION OFFICER) | Grant or award | +62,500 | — | — |
| Feb 19, 2026 | Jennifer Lew Officer (EVP & CHIEF FINANCIAL OFFICER) | Grant or award | +62,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.